Procept biorobotics stock.

2 พ.ย. 2566 ... Throughout the day, the stock's price fluctuated within a range of $1.07 to $1.30. The trading volume for the day was 843,205 shares, which is ...

Procept biorobotics stock. Things To Know About Procept biorobotics stock.

The fluctuation in the stock market for PROCEPT BioRobotics coincides with abrdn plc’s strategic decision to increase its holdings. Despite opening at $36.10 on Tuesday, PRCT stock has experienced significant volatility over the last twelve months, ranging from a low of $25.29 to a high of $52.40. It is evident that market conditions have …Contact Email [email protected]. Phone Number 650-232-7200. PROCEPT is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for …Procept Biorobotics Corp stock performance at a glance. Check Procept Biorobotics Corp’s past financial performance, like revenue or net income, plus the top level …Apr 19, 2023 · Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 20.7% so far this month. During the month of April, Procept Biorobotics Corp’s stock price has reached a high of $37.29 and a low of $28.80. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $25.90. Year ... PROCEPT BioRobotics (NASDAQ:PRCT) is gearing up to release its financial results for the quarter on Thursday, July 27th. Analysts have Anticipation Builds for PROCEPT BioRobotics Earnings Announcement: Institutional Investments and Analyst Ratings Awaited - Best Stocks

Oct 1, 2023 · PROCEPT BioRobotics’ stock opened at a price of $33.27 on Friday. The company boasts a current ratio of 6.40 and a quick ratio of 5.21 while maintaining a debt-to-equity ratio of 0.34. Notably, the company’s fifty-day simple moving average stands at $33.35 with a 200-day simple moving average at $33.23. PROCEPT BioRobotics Corporation (NASDAQ:PRCT) shares have had a really impressive month, gaining 32% after a shaky period beforehand. Not all shareholders will be feeling jubilant, since the share ...PROCEPT BioRobotics Stock Up 2.9 %. PRCT stock opened at $34.70 on Friday. The company has a quick ratio of 7.89, a current ratio of 8.91 and a debt-to-equity ratio of 0.18. PROCEPT BioRobotics Co ...

Real time Procept BioRobotics (PRCT) stock price quote, stock graph, news & analysis. ... PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the ...

Procept Biorobotics Corp’s ( PRCT) price is currently down 24.19% so far this month. During the month of March, Procept Biorobotics Corp’s stock price has reached a high of $38.07 and a low of $28.28. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $28.30. Year to date, Procept Biorobotics Corp ...PROCEPT BioRobotics Corporation Common Stock (PRCT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Procept Biorobotics Corp (PRCT) stock is up 1.62% while the S&P 500 is lower by -0.07% as of 2:07 PM on Thursday, Nov 30. PRCT has risen $0.60 from the …PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to loss of $0.39 per share a year ago ...On Wednesday, Procept BioRobotics Corp [NASDAQ: PRCT] rose 9.56% to $37.00. The stock’s lowest price that day was $34.01, but it reached a high of $37.03 in the same session. During the last five days, there has been a surge of approximately 9.73%. Over the course of the year, Procept BioRobotics Corp shares have dropped …

PROCEPT BioRobotics Corporation is a surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with …

Procept Biorobotics Corp’s ( PRCT) price is currently down 24.19% so far this month. During the month of March, Procept Biorobotics Corp’s stock price has reached a high of $38.07 and a low of $28.28. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $28.30. Year to date, Procept Biorobotics Corp ...

SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third... 12 Oct '23.PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.42 per share a year ago.2 พ.ย. 2566 ... Throughout the day, the stock's price fluctuated within a range of $1.07 to $1.30. The trading volume for the day was 843,205 shares, which is ...B. Riley Lowers PROCEPT BioRobotics' PT to $55 From $60 on Lower Multiple, Keeps Buy Rating. Nov. 02. MT. Transcript : PROCEPT BioRobotics Corporation, Q3 2023 Earnings Call, Nov 01, 2023. Nov. 01. CI. Earnings Flash (PRCT) PROCEPT BIOROBOTICS Posts Q3 Revenue $35.1M, vs. Street Est of $33.4M. Nov. 01.Stock Chart. Technical Analysis. Tools & Settings. Open High Low Volume. Volume. The Investor Relations website contains information about PROCEPT BioRobotics Corp's business for stockholders, potential investors, and financial analysts. PROCEPT BioRobotics also expects to grant the underwriters a 30-day option to purchase up to an additional $18,750,000 of shares of its common stock. The offering is subject to market and other ...About PROCEPT BioRobotics Corporation PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use …

Nov 30, 2023 · Verdict: PROCEPT BioRobotics lost $1.96 a share on $75 million worth of revenue in FY2022. The current analyst firm consensus has that loss expanding a bit in FY2023 to $2.13 a share even as sales ... REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ...Procept Biorobotics Corp’s ( PRCT) price is currently down 24.19% so far this month. During the month of March, Procept Biorobotics Corp’s stock price has reached a high of $38.07 and a low of $28.28. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $28.30. Year to date, Procept …Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.Stock Symbol NASDAQ:PRCT · Valuation at IPO $1.1B · Money Raised at IPO $163.9M · IPO Share Price $25.00 · IPO Date Sep 15, 2021 ...

REDWOOD CITY, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...

According to 4 analyst offering 12-month price targets in the last 3 months, PROCEPT BioRobotics has an average price target of $49.75 with a high of $58.00 and a low of $44.00. Below is a summary ...On a more positive note, William Blair initiated coverage on PROCEPT BioRobotics with an “outperform” rating on the stock back in May. Based on data compiled by Bloomberg, PROCEPT BioRobotics currently holds a consensus rating of “Moderate Buy” among equity research analysts, with a consensus target price of $45.60 indicating optimism ...Feb 28, 2023 · REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ... PROCEPT BioRobotics Corporation is a surgical robotics company, which is focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures and sells the AquaBeam Robotic System, which is an image-guided surgical robotic system for use in minimally invasive urologic surgery, with …SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023.2007. 428. Reza Zadno. https://www.procept-biorobotics.com. PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating ...Thursday, April 27, 2023 - Procept Biorobotics Corp ( PRCT) reported downside earnings and upside revenues. Procept Biorobotics Corp's earnings came in at an EPS loss of $0.63 per share, 9% lower than estimates for an EPS loss of $0.58 per share. The firm's loss per share expanded by 62% since reporting a loss of $0.39 per share a year ago.

PROCEPT BioRobotics Trading Up 0.8 %. NASDAQ PRCT opened at $37.36 on Monday. The stock has a market capitalization of $1.89 billion, a price-to-earnings ratio of -16.03 and a beta of 0.98.

PROCEPT BioRobotics Stock Performance Shares of NASDAQ PRCT opened at $32.82 on Tuesday. The company has a market cap of $1.49 billion, a PE ratio of -14.09 and a beta of 0.63.

Aug 1, 2023 · REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care ... Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently down 17.97% so far this month. During the month of March, Procept Biorobotics Corp’s stock price has reached a high of $38.07 and a low of $29.82. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as …REDWOOD CITY, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing ...Thursday, April 27, 2023 - Procept Biorobotics Corp ( PRCT) reported downside earnings and upside revenues. Procept Biorobotics Corp's earnings came in at an EPS loss of $0.63 per share, 9% lower than estimates for an EPS loss of $0.58 per share. The firm's loss per share expanded by 62% since reporting a loss of $0.39 per share a year ago.About PRCT. PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).Webull offers Procept Biorobotics Corp stock information, including NASDAQ: PRCT real-time market quotes, financial reports, professional analyst ratings, ...May 2, 2023 · Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently down 6.05% so far this month. During the month of May, Procept Biorobotics Corp’s stock price has reached a high of $31.82 and a low of $27.90. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $25.29. Year ... Currently, Procept BioRobotics Corp [PRCT] is trading at $37.00, up 9.56%. In order to assess the stock's recent performance, you can check whether its …

Procept Biorobotics reels in $85M to make a splash with water-based robotic system for prostate surgery By Andrea Park Jun 30, 2021 10:00am Aquablation benign prostatic hyperplasia medical device ...SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023. Recent …About PRCT. PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).Instagram:https://instagram. fmna stockbest day trading platform for small accountskmi tickertrackmydividends On January 9, 2023, PROCEPT BioRobotics Corporation (the "Company") issued a press release announcing its preliminary revenue results for the quarter and fiscal year ended December 31, 2022. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.Main Lobby Procept BioRobotics Main Lobby Main Entrance Procept BioRobotics Main Entrance SAN JOSE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT ... best cryptocurrency exchange ukenergy source minerals stock symbol REDWOOD CITY, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2023.. Recent … best ipo broker Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.PROCEPT BioRobotics Corporation RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (Unaudited, in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022: Net loss $ (24,622) $ (22,613) $ (78,393) $ (58,982) Depreciation and amortization expense 1,054 703 2,489 2,178 Stock-based compensation expense 5,326 ...